Cha Vaccine Institute to Change Listing to AriBio Lab on the 29th
Transition to an Immune-Based Bio Platform for Degenerative Brain Diseases
Cha Vaccine Institute announced on the 22nd that, due to a change of corporate name, it will begin trading as AriBio Lab starting from the 29th.
With this change of listing, AriBio Lab will transition into a next-generation immune-based bio-platform company focused on degenerative brain diseases. The company, together with AriOne (formerly Solux) and AriBio, will pursue an integrated growth strategy connecting Alzheimer's treatments, preventive vaccines, immune platforms, and artificial intelligence (AI) and data-driven healthcare.
A strategic restructuring of the group's bio business structure will also take place. Under the 'AriOne' system of Solux, AriBio will be responsible for the development of Alzheimer's treatments, while AriBio Lab will focus on prevention through vaccine and immune platform development. AriBio is currently conducting a global Phase 3 clinical trial of its oral Alzheimer's treatment AR10001, and AriBio Lab has been strengthening its vaccine development capabilities based on its proprietary immune-boosting platforms L-pampo™ and Lipo-pam™ technologies.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A company representative stated, "If AriOne takes the central role as the future growth platform, and AriBio and AriBio Lab each take charge of therapeutics and prevention platforms, the group's bio growth potential will become much clearer."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.